Core Viewpoint - Harbin Sanlian Pharmaceutical Co., Ltd. plans to expand its business scope to include the production of plastic packaging containers for food, following the approval of the board of directors and pending shareholder approval [1][5]. Business Scope Change - The company's previous business scope included various pharmaceutical and healthcare-related activities such as drug production, wholesale, retail, and medical device manufacturing [2][4]. - The new business scope will add "production of plastic packaging containers for food" to its existing operations, which encompass drug production, cosmetics production, food production, and medical device manufacturing [2][4]. Company Charter Revision - The company has revised its charter to reflect the changes in its business scope, ensuring that the new activities are officially documented [3][5]. - The charter revision maintains all other provisions unchanged, and the board has requested authorization from the shareholders to handle subsequent business registration procedures [5].

Core Viewpoint - The company, Haosai Technology Group Co., Ltd., is planning to change its registered address and business scope, which requires approval from the shareholders' meeting and subsequent registration with the relevant authorities [1][7]. Change of Registered Address and Business Scope - The registered address will change from Room 1902 to Room 1903 at the same location in Haidian District, Beijing [2][5]. - The business scope will be adjusted but the main business direction and operational status will remain unchanged [1][6]. Amendments to the Articles of Association - The Articles of Association will be revised to reflect the new registered address and updated business scope [4][5]. - Specific changes include the updated address and the addition of electric vehicle charging infrastructure operations and project planning and public relations services to the business scope [5][6]. Authorization for Change Procedures - The board of directors seeks authorization from the shareholders' meeting to handle all necessary procedures related to the changes [7]. - The final content of the changes will be subject to approval by the market supervision and management department [7].